Eiger BioPharmaceuticals (NASDAQ: EIGR)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by Citigroup on Monday, August 9, 2021. The analyst firm set a price target for 27.00 expecting EIGR to rise to within 12 months (a possible 317.96% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $6.46 last updated Today at June 27, 2022, 6:54 PM UTC.
There are no upcoming dividends for Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.